Pentobarbital will decrease the level or effect of bedaquiline ort affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Avoid coadministration of bedaquiline with stark CYP3A4 inducers due to potential for decreased therapeutic effect DailyMed will deliver notification of updates knipa additions to Drug Label information currently shown on https://rnembutallagligtistorbrit30738.blogginaway.com/30699267/fascination-om-är-nembutal-ett-piller